Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemotherapy with Stem Cell Support in Ovarian Cancer
NCT00003064Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Jan 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Herbert Irving Comprehensive Cancer Center. Status: unknown.
02
Drugs
topotecan
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00003064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003064.